Richard B. Lanman is Chief Medical Officer at Guardant Health, Inc. (GH). They have made 8 open-market trades across 1 company since 2019, most recently 2019-11-01.
CIK 0001721003
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 8 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| GH | 82,015 | $13.0M |
Shares reported on the most recent Form 4, priced at the 2019-11-05 close.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| GH | SELL | 2019-11-01 | 2019-11-05 | $69.96 | $806K | +18.1% | +8.6% | +15.7% |
| GH | SELL | 2019-08-09 | 2019-08-13 | $105.39 | $4.9M | -4.5% | -22.2% | -26.3% |
| GH | SELL | 2019-08-09 | 2019-08-13 | $105.25 | $6.6M | -4.5% | -22.2% | -26.3% |
| GH | SELL | 2019-05-16 | 2019-05-20 | $80.00 | $135K | +2.0% | +18.7% | +31.8% |
| GH | SELL | 2019-05-01 | 2019-05-03 | $64.84 | $249K | +21.7% | +22.8% | +48.4% |
| GH | SELL | 2019-05-01 | 2019-05-03 | $64.49 | $170K | +21.7% | +22.8% | +48.4% |
| GH | SELL | 2019-04-17 | 2019-04-17 | $72.20 | $3.3M | -9.8% | +4.9% | +22.1% |
| GH | SELL | 2019-04-15 | 2019-04-17 | $74.43 | $10.1M | -9.8% | +4.9% | +22.1% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.